AI summary Trust: medium Third-party lab

LabE tested this tirzepatide batch (ZE60-1123) at 99.9% purity via HPLC. However, the tested quantity was 52.1mg against a 60mg label, representing a significant -13.2% deviation. Endotoxin status is not applicable, and the test is recent (under 3 months). Customers can cross-check on the lab's public verification URL.

Watch out for
  • significant quantity deviation
  • no endotoxin test
Test date
2026-03-06
Purity
99.90% 99.90%
Batch / lot
ZE60-1123
Lab
LabE
Quantity
label 60mg tested 52.1mg
Qty vs label
-13.2%
Endotoxins
n/a
Test score
7.9
Manufacturer
Uther Peptide
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
60mg
Container
Clear Label / Gold Crimp / Clear Red Cap
Catalogued
2026-04-17
Artifact hash
d84a9dbafc669d99…
This COA is part of TitrateLab's community-trust corpus. See more from Uther Peptide or learn how trust scores are computed on the methodology page.